3.連結財務諸表及び主な注記

(1)連結財政状態計算書

 

 

 

(単位:百万円)

 

前連結会計年度

(2024年3月31日)

 

当連結会計年度

(2025年3月31日)

資産

 

 

 

流動資産

 

 

 

現金及び現金同等物

47,044

 

39,592

営業債権

73,802

 

70,530

棚卸資産

52,651

 

51,694

その他の金融資産

4,775

 

4,308

その他の流動資産

9,575

 

6,665

流動資産合計

187,849

 

172,790

非流動資産

 

 

 

有形固定資産

49,708

 

48,374

のれん

208,719

 

206,500

無形資産

91,388

 

80,649

持分法で会計処理されている投資

2,188

 

1,821

その他の金融資産

13,987

 

13,932

繰延税金資産

7,058

 

6,120

その他の非流動資産

3,426

 

2,293

非流動資産合計

376,477

 

359,691

資産合計

564,327

 

532,482

 

 

 

 

 

(単位:百万円)

 

前連結会計年度

(2024年3月31日)

 

当連結会計年度

(2025年3月31日)

負債及び資本

 

 

 

負債

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

69,881

 

65,665

借入金

36,922

 

34,278

未払法人所得税等

2,311

 

4,207

引当金

6,587

 

7,725

その他の金融負債

6,251

 

5,812

その他の流動負債

25,445

 

22,865

流動負債合計

147,400

 

140,555

非流動負債

 

 

 

営業債務及びその他の債務

847

 

597

借入金

248,123

 

220,982

退職給付に係る負債

5,709

 

5,544

引当金

3,431

 

4,575

その他の金融負債

9,200

 

8,358

繰延税金負債

9,109

 

9,291

その他の非流動負債

1,340

 

1,405

非流動負債合計

277,763

 

250,755

負債合計

425,163

 

391,310

資本

 

 

 

資本金

48,423

 

48,623

資本剰余金

41,797

 

42,039

利益剰余金

2,773

 

2,991

自己株式

568

 

568

その他の資本の構成要素

52,635

 

48,553

親会社の所有者に帰属する持分合計

139,515

 

141,639

非支配持分

351

 

468

資本合計

139,163

 

141,171

負債及び資本合計

564,327

 

532,482

 

E3697665230PHCホールディングス株式会社PHC Holdings Corporation通期第3号参考様式 [IFRS](連結)IFRStrueCTECTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse652302023-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-03-31jpigp_cor:TreasurySharesIFRSMember652302023-03-31jpigp_cor:RetainedEarningsIFRSMember652302023-03-31jpigp_cor:CapitalSurplusIFRSMember652302023-03-31jpigp_cor:ShareCapitalIFRSMember652302025-05-13652302025-03-31652302024-04-012025-03-31652302024-03-31652302023-04-012024-03-31652302023-03-31652302025-03-31jpigp_cor:NonControllingInterestsIFRSMember652302025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302025-03-31jpigp_cor:TreasurySharesIFRSMember652302025-03-31jpigp_cor:RetainedEarningsIFRSMember652302025-03-31jpigp_cor:CapitalSurplusIFRSMember652302025-03-31jpigp_cor:ShareCapitalIFRSMember652302024-04-012025-03-31jpigp_cor:NonControllingInterestsIFRSMember652302024-04-012025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-04-012025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-04-012025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-04-012025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-04-012025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-04-012025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-04-012025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-04-012025-03-31jpigp_cor:TreasurySharesIFRSMember652302024-04-012025-03-31jpigp_cor:RetainedEarningsIFRSMember652302024-04-012025-03-31jpigp_cor:CapitalSurplusIFRSMember652302024-04-012025-03-31jpigp_cor:ShareCapitalIFRSMember652302024-03-31jpigp_cor:NonControllingInterestsIFRSMember652302024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-03-31jpigp_cor:TreasurySharesIFRSMember652302024-03-31jpigp_cor:RetainedEarningsIFRSMember652302024-03-31jpigp_cor:CapitalSurplusIFRSMember652302024-03-31jpigp_cor:ShareCapitalIFRSMember652302023-04-012024-03-31jpigp_cor:NonControllingInterestsIFRSMember652302023-04-012024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-04-012024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-04-012024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-04-012024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302023-04-012024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-04-012024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-04-012024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-04-012024-03-31jpigp_cor:TreasurySharesIFRSMember652302023-04-012024-03-31jpigp_cor:RetainedEarningsIFRSMember652302023-04-012024-03-31jpigp_cor:CapitalSurplusIFRSMember652302023-04-012024-03-31jpigp_cor:ShareCapitalIFRSMember652302023-03-31jpigp_cor:NonControllingInterestsIFRSMember652302023-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember652302024-04-012025-03-31tse-acediffr-65230:DiabetesManagementReportableSegmentMember652302024-04-012025-03-31tse-acediffr-65230:HealthcareSolutionsReportableSegmentMember652302024-04-012025-03-31tse-acediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember652302023-04-012024-03-31jpcrp_cor:ReportableSegmentsMember652302023-04-012024-03-31tse-acediffr-65230:DiabetesManagementReportableSegmentMember652302023-04-012024-03-31tse-acediffr-65230:HealthcareSolutionsReportableSegmentMember652302023-04-012024-03-31tse-acediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302023-04-012024-03-31jpcrp_cor:ReconcilingItemsMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure